Juno Therapeutics, A Subsidiary Of Celgene

This early-stage study tested an experimental drug called CC-95266 in 130 adults with multiple myeloma that had returned or stopped responding to previous treatments. The main goal was to find the safest dose and check for side effects, while also looking for early signs that the…